Supplemental material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma Beatriz Asenjo García Félix Navarro Guirado Fátima Nagib Raya María Vidal Denis Francisco Bravo Rodríguez Pedro Galán Montenegro 10.25384/SAGE.9167210.v1 https://sage.figshare.com/articles/journal_contribution/Supplemental_material_for_ADC_quantification_to_classify_patients_candidate_to_receive_bevacizumab_treatment_for_recurrent_glioblastoma/9167210 <p>Supplemental Material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma by Beatriz Asenjo García, Félix Navarro Guirado, Fátima Nagib Raya, María Vidal Denis, Francisco Bravo Rodríguez and Pedro Galán Montenegro in Acta Radiologica</p> 2019-07-30 12:18:32 Antiangiogenic drug bevacizumab glioma imaging biomarker magnetic resonance diffusion-weighted imaging